The cancer diagnoses of King Charles III and Catherine, Princess of Wales, in early 2024 generated extraordinary media attention across the United Kingdom and around the world. The announcements, delivered on February 5 in the case of the King and March 22 in the case of the Princess, dominated news cycles for weeks and prompted widespread public conversation about cancer symptoms, screening, treatment approaches, and prognosis. Because both royals had been highly visible public figures, the disclosures were seen as potentially transformative moments for public awareness of cancer, and indeed they did encourage many people to seek information and medical advice. Yet alongside this heightened awareness came another, far less visible problem: the widespread circulation of inaccurate information about cancer and cancer care. A new study published in the scientific journal ecancermedicalscience has found that approximately one in four UK newspaper stories analyzed in the immediate aftermath of these royal diagnoses contained false or factually inaccurate claims about cancer, treatment, or oncology practice. The analysis was conducted by researchers affiliated with some of Britain’s most respected medical and academic institutions, including The Royal Marsden NHS Foundation Trust, King’s College London, the Royal College of Surgeons of England, the London School of Hygiene & Tropical Medicine, and Guy’s and St Thomas’ NHS Foundation Trust. The findings add important evidence to the ongoing discussion about royal cancer coverage and raise a broader question that extends well beyond the Royal Family: when millions of people turn to newspapers and news websites for cancer information, how accurate is what they are actually being told? According to this study, a substantial portion of the cancer-related journalism published during one of the most closely watched health stories in recent British history failed to meet basic standards of medical accuracy, underscoring concerns about the reliability of health information in mainstream media and the potential consequences for patient expectations, health behaviors, and public understanding of modern oncology.
Researchers examined UK newspaper coverage following the two royal announcements, focusing on the 40 days immediately after each diagnosis, when public interest and media scrutiny were at their peak. The team searched 19 major UK newspapers and news websites and identified 72 stories that contained specific claims related to cancer or cancer care. Each story was systematically analyzed for the subjects discussed, the professional backgrounds of the journalists, the credibility and qualifications of quoted sources, and the accuracy of cancer-related claims. Two experienced oncologists independently assessed those claims using a five-point rating scale ranging from entirely correct to clearly incorrect, and the results were striking. Of the 72 stories analyzed, 19, or 26 percent, were deemed factually incorrect and contained false cancer-related claims. Six stories were judged entirely incorrect in the cancer information they presented, while a further 13 stories contained at least some factual inaccuracies. The study was designed not to quantify every instance of cancer misinformation in UK media, but rather to assess the accuracy of reporting during a defined period of intense public interest, making the findings a case study in how health information is communicated during major news events. The misinformation was not evenly distributed across topics. Among the 19 inaccurate stories, 47 percent involved standard cancer treatments, 21 percent involved cancer epidemiology, and 16 percent involved complementary and alternative medicine. The concentration of misinformation in tabloid newspapers was particularly notable: 16 of the 19 inaccurate stories appeared in tabloid publications, raising questions about editorial standards and medical fact-checking in that sector of the press. Source credibility also emerged as a significant concern. In ten of the 19 inaccurate stories, the journalist did not have a background in health journalism, and in two cases no journalist was named at all. The wider sample also included cancer claims attributed to individuals with no medical background or with qualifications that were not clearly stated, making it difficult for readers to assess the trustworthiness of the information being presented.
The specific examples of misinformation identified by the researchers illustrate how easily complex oncology concepts can become distorted when translated into headlines and simplified narratives. One recurring theme involved chemotherapy. Some stories presented chemotherapy as “often curative on its own,” a claim that ignores the clinical reality that chemotherapy’s purpose varies substantially according to cancer type, stage, biology, and overall treatment strategy. While chemotherapy can be curative in certain specific cancers and clinical settings, many regimens are palliative, designed to control symptoms and prolong survival, while others are delivered in combination with surgery or radiotherapy as part of a multimodal approach. Presenting chemotherapy broadly as curative risks creating unrealistic expectations about what treatment can achieve, an issue the researchers highlight as a broader concern in cancer reporting. Conversely, other stories claimed that chemotherapy is only used for potentially curable cancers, which is equally misleading. Systemic therapies are widely used in advanced and metastatic cancers where cure may not be possible, helping to slow disease progression, extend life, relieve symptoms, and improve quality of life. Cancer treatment, the authors emphasize, cannot be neatly divided into curative treatment and no treatment. Another example involved non-small cell lung cancer, with one story claiming that it is usually treated with surgery. In reality, treatment depends heavily on stage, tumor characteristics, and whether the disease can be surgically removed, and many patients require systemic therapy, radiotherapy, or a combination of multiple modalities. Additional inaccuracies included portraying hair loss as an inevitable consequence of cancer treatment, despite the fact that many modern therapies do not cause complete hair loss, and suggesting that homeopathy can treat cancer, despite the complete absence of scientific evidence supporting such claims. The study also identified an article suggesting that patients should bypass general practitioners because blood tests could more reliably assess cancer risk, despite the fact that there is currently no universal blood test capable of diagnosing all cancers, and that indiscriminate testing can generate false positives, unnecessary investigations, and added pressure on healthcare services. Another item suggested that a solar eclipse could represent a hopeful sign for the Princess’s recovery, an example of information with no clinical relevance being inserted into cancer coverage.
Why does misinformation in royal cancer coverage matter? The answer lies in the extraordinary visibility of these stories and the influence they exert on public beliefs, attitudes, and behaviors. Cancer diagnoses involving prominent public figures attract enormous attention, and that attention can have genuinely positive effects. Public disclosures may encourage people to learn about cancer symptoms, undergo appropriate screening, or consult healthcare professionals about concerns they had been postponing. But the same visibility also creates an environment in which speculation can spread rapidly. When limited clinical information is available, as was the case with both royal diagnoses, journalists may attempt to fill the gaps by explaining possible treatments, likely prognoses, or supposed causes without knowing the exact diagnosis, stage, molecular characteristics, or treatment plan. In oncology, those details matter enormously. Two individuals with the same broad cancer type may receive very different treatments and have very different prognoses depending on stage, tumor biology, genetic biomarkers, overall health, and other individual factors. The study authors emphasize that media reporting can influence beliefs, health behavior, treatment expectations, and even clinical decision-making, meaning that inaccurate reporting carries real consequences for patients and their families. The findings reflect a wider challenge in health communication. Cancer stories compete for attention in an environment where dramatic headlines, personal narratives, and simple conclusions often prove easier to communicate than the uncertainty and complexity inherent in medicine. Previous research cited by the authors suggests that media coverage tends to overemphasize the potential effectiveness of cancer drugs while devoting far less attention to treatment failure, side effects, or toxicity, and this matters because patients may already hold unrealistic expectations about the curative potential of treatment. The study also highlights the importance of source credibility. When a story quotes a named oncologist, an established medical organization, or a recognized cancer institution, readers have the tools to assess the reliability of the information. But vague descriptions such as “leading doctors” or “medical experts” without naming those individuals make such assessment considerably harder. Greater transparency around sourcing, the authors argue, is not merely an editorial preference but an essential component of responsible health communication.
The challenge of cancer misinformation extends well beyond print newspapers, and the study authors argue that further investigation into cancer misinformation on social media is urgently needed. Digital platforms may present an even greater risk than traditional media, as inaccurate or sensational health information can reach vast audiences within minutes. The authors cite research showing that social media posts containing health misinformation often achieve higher engagement than factual content, a disturbing dynamic in an era when algorithms reward attention rather than accuracy. Cancer is particularly vulnerable to this phenomenon because patients and their families frequently search for information during moments of uncertainty and fear. Claims involving miracle cures, hidden treatments, or dramatic breakthroughs can therefore attract considerable traction online. For medical media, healthcare organizations, and clinicians, publishing accurate information alone may no longer be sufficient; accurate information also needs to be clear, accessible, timely, and easy to verify. The good news is that better cancer reporting is entirely achievable. The study authors offer a series of practical recommendations for journalists and editors: name and credential every expert or organization quoted; rely on established medical organizations and peer-reviewed research wherever possible; distinguish clearly between curative-intent and palliative-intent treatment; avoid discussing prognosis without adequate clinical information, including cancer type, stage, and relevant biomarkers; explain that treatment decisions vary according to cancer type, stage, molecular characteristics, and individual patient factors; clearly distinguish supportive or complementary care from disease-modifying treatment; identify unsupported alternative treatment claims as lacking evidence; explain the limitations of diagnostic tests rather than presenting them as universal solutions; and correct inaccurate information transparently when errors are identified. The study authors specifically call for stricter verification standards, greater transparency regarding source credibility, improved education for journalists and editors, and stronger collaboration between the press and the healthcare community. Closer cooperation between journalists and medical professionals could help ensure that complex oncology information is communicated accurately without becoming inaccessible to the general public, and that the lessons from this analysis of royal cancer coverage inform broader improvements in health journalism.
The study has important limitations that must be acknowledged. Researchers examined only 72 eligible stories published during a 40-day window following two highly unusual public cancer announcements, and the relatively small sample size prevented meaningful statistical analysis. The findings should not be interpreted as showing that one quarter of all UK cancer journalism is inaccurate; rather, the authors describe the analysis as providing a reasonable indication of national reporting trends while calling for further research. It is also worth distinguishing between misinformation and disinformation, terms that are often used interchangeably but carry different meanings. Health misinformation refers to information that is inaccurate or misleading based on established scientific knowledge or the best available evidence, and it may be shared unintentionally, as when a complex cancer treatment is oversimplified, an outdated claim is repeated, or a journalist relies on an unreliable source. Disinformation, by contrast, involves false or misleading information that is deliberately created or shared to advance a political, ideological, commercial, or other agenda. The key difference is intent: misinformation can spread without someone meaning to deceive, while disinformation is knowingly misleading. In cancer communication, both can be harmful. An inaccurate claim about chemotherapy, prognosis, screening, or alternative medicine may influence how patients and families understand their options, regardless of whether the error was deliberate, which is why responsible cancer reporting depends not only on avoiding false information but also on checking sources, verifying medical claims, and clearly separating established evidence from speculation or opinion. Cancer misinformation can have consequences far beyond a misleading headline: it can create unnecessary fear, unrealistic expectations, or mistrust in medical care, and it can influence decisions at a time when people are especially vulnerable. The biggest message from this study, however, is a constructive one. The royal cancer diagnoses brought cancer into millions of conversations, and that visibility can improve awareness, encourage appropriate screening, and normalize discussions around diagnosis and treatment. But greater attention also creates greater responsibility. When reporting on cancer, an inaccurate statement about chemotherapy, prognosis, or alternative medicine is more than a simple factual error; for someone making decisions about their health, it can influence expectations, behavior, and trust in medical care. Cancer information matters. The source matters. And when health information reaches millions of people, accuracy matters even more.
